Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.050 Biomarker disease BEFREE These results support the hypothesis that aberrant nuclear GSK-3β may represent a potential target for the clinical treatment of human breast and squamous cell carcinoma. 30405781 2018
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.050 AlteredExpression disease BEFREE Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion. 29134466 2018
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.050 Biomarker disease BEFREE Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma. 29176314 2017
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.050 Biomarker disease BEFREE miRNA-99b-3p functions as a potential tumor suppressor by targeting glycogen synthase kinase-3β in oral squamous cell carcinoma Tca-8113 cells. 26315788 2015
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.050 GeneticVariation disease BEFREE To clarify the role of cytoplasmic accumulation of β-catenin in oral squamous cell carcinoma (SCC), the cDNA of a mutant form of β-catenin that lacks the entire region with the glycogen synthase kinase-3 β (GSK-3β)-specific phosphorylation site was transfected into Ca9-22 cells whose β-catenin had been expressed predominantly at the membrane, and permanent cell lines expressing aberrant β-catenin in the cytoplasm and nucleus were produced. 20878057 2010